Welcome to our dedicated page for Enovix SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enovix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enovix's regulatory disclosures and financial reporting.
Rodgers Thurman J reported acquisition or exercise transactions in this Form 4 filing.
Enovix Corp director and 10% owner Thurman J. Rodgers received a grant of 29,104 restricted stock units (RSUs) of Enovix common stock. The award was granted on June 11, 2026 at a price of $0.00 per share as compensation, not an open‑market purchase.
Each RSU represents a contingent right to receive one Enovix common share. Vesting will occur in four equal 25% installments on September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the date of Enovix’s 2027 annual stockholder meeting, subject to his continued service.
Following this grant, Rodgers directly holds 34,740 Enovix common shares, including the 29,104 shares underlying the RSUs. He also has indirect ownership through two trusts where he serves as trustee with voting and dispositive power, holding 1,120,114 and 20,875,314 Enovix common shares, respectively.
Enovix Corp Chief Accounting Officer Kristina Truong reported a routine tax-related share adjustment. On the vesting of restricted stock units, 253 shares of common stock were withheld to cover tax obligations at $6.28 per share. After this withholding, she holds 315,369 common shares, including 220,610 shares tied to unvested RSUs and earned performance RSUs scheduled for release between March 2027 and April 2028.
Enovix Corporation reported the results of its 2026 Annual Meeting of Stockholders. Holders of 153,161,477 common shares, representing 70.3% of voting power as of the April 13, 2026 record date, were present in person or by proxy, establishing a quorum.
Stockholders elected all eight director nominees to one-year terms, with each receiving more votes "for" than "withheld." They also approved, on an advisory basis, the compensation of the company’s named executive officers. In addition, stockholders ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending January 3, 2027.
Enovix Corp President and CEO Rajendra K. Talluri had 4,301 shares of common stock withheld on June 8, 2026 to cover tax obligations tied to vesting restricted stock units (RSUs). The shares were valued at $7.32 each for the withholding calculation.
After this tax-withholding disposition, Talluri holds 3,062,266 shares directly, a figure that includes 1,989,823 shares issuable upon vesting and settlement of RSUs. His position also reflects 47,775 vested performance RSUs scheduled for release in March 2027 and 259,611 additional performance RSUs, half to be released in April 2027 and the rest in April 2028.
Enovix Corp reported that Chief Legal Officer Arthi Chakravarthy had 936 shares of common stock withheld at $7.32 per share to cover tax obligations tied to vesting restricted stock units. After this tax-withholding disposition, she holds 603,576 common shares, including 389,432 shares issuable from RSUs and additional performance RSUs scheduled for release between March 2027 and April 2028.
Enovix Corp Chief Accounting Officer Kristina Truong reported routine equity compensation activity involving restricted stock units. On May 29, 2026 she received 5,718 shares of common stock from a fully vested RSU award, with 3,028 shares withheld at $7.98 per share to cover tax obligations. After these transactions, she directly held 315,622 shares of Enovix common stock, including shares underlying previously granted RSUs and performance RSUs that will be settled in 2027 and 2028.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported routine equity compensation activity. On May 29, 2026, she received 6,756 shares of common stock at no cost as a fully vested RSU bonus for the quarter ended April 5, 2026, and 3,578 shares were withheld to cover tax obligations. Following these transactions, she directly holds 604,512 common shares, in addition to a substantial mix of unvested RSUs and earned performance RSUs scheduled to settle between 2027 and 2028.
Enovix Corp Chief Financial Officer Ryan A. Benton reported routine equity compensation activity involving restricted stock units (RSUs). On May 29, 2026, he received 5,103 shares of common stock as a fully vested RSU award bonus for the quarter ended April 5, 2026, and 2,703 shares were withheld to cover related tax obligations. Following these transactions, he directly owned 925,368 shares of Enovix common stock, including 848,005 shares issuable upon future vesting and settlement of RSUs. These events reflect compensation and tax withholding mechanics, not open-market stock purchases or sales.
Enovix Corp President and CEO Rajendra K. Talluri reported routine equity compensation and related tax withholding in company stock. He received 17,794 shares of common stock at no cost on May 29, 2026 from a fully vested restricted stock unit (RSU) bonus for the quarter ended April 5, 2026.
To cover tax obligations on this award, 9,422 shares were withheld at $7.98 per share, a non-market disposition. After these transactions, he is reported as beneficially owning 3,066,567 shares, including 1,997,944 shares issuable upon RSU vesting and additional performance RSUs scheduled to settle in 2027 and 2028.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a routine tax-related share disposition. On the reported date, 2,221 shares of Enovix common stock were withheld at $6.68 per share to cover tax obligations tied to vesting restricted stock units. After this withholding, Chakravarthy directly held 601,334 shares. The position includes 391,199 shares issuable from unvested RSUs and performance-based awards scheduled to settle between March 2027 and April 2028, indicating a substantial remaining equity stake.